Midecamycin: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File:Midecamycin.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | [[File:Midecamycin.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Midecamycin''' is a [[macrolide]] [[antibiotic]]. Synthesized from ''Streptomyces mycarofaciens''. | '''Midecamycin''' is a [[macrolide]] [[antibiotic]]. Synthesized from ''Streptomyces mycarofaciens''. | ||
==Physical Properties== | ==Physical Properties== | ||
[[Melting point]] vary depending on the compound type. It may also vary depending on the source consulted. Example: | [[Melting point]] vary depending on the compound type. It may also vary depending on the source consulted. Example: | ||
Line 23: | Line 18: | ||
The Merck Index reports 122-125 Celsius. | The Merck Index reports 122-125 Celsius. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 20:02, 7 April 2015
WikiDoc Resources for Midecamycin |
Articles |
---|
Most recent articles on Midecamycin Most cited articles on Midecamycin |
Media |
Powerpoint slides on Midecamycin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Midecamycin at Clinical Trials.gov Clinical Trials on Midecamycin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Midecamycin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Midecamycin Discussion groups on Midecamycin Patient Handouts on Midecamycin Directions to Hospitals Treating Midecamycin Risk calculators and risk factors for Midecamycin
|
Healthcare Provider Resources |
Causes & Risk Factors for Midecamycin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Midecamycin is a macrolide antibiotic. Synthesized from Streptomyces mycarofaciens.
Physical Properties
Melting point vary depending on the compound type. It may also vary depending on the source consulted. Example:
For the A1 type:
The Merck Index reports 155-156 Celsius. The Japanese Pharmacopoeia reports 153–158 Celsius.
For the A3 type:
The Merck Index reports 122-125 Celsius.
References